-
Intussusception as the first manifestation of disseminated aspergillosis in a patient with autologous hematopoietic stem cell transplantation Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-16 Ricardo Augusto Diaz‐Sanabria, Isabel Cristina Ramírez‐Sánchez
-
Rat hepatitis E in kidney transplant recipients: Case studies and review of literature Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-16 Chi Yuen Cheung, Koon Ming Chan, Siddharth Sridhar
-
Effect of letermovir initiation on tacrolimus concentrations among lung transplant recipients receiving concomitant azole antifungal prophylaxis Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-16 Kellie J. Goodlet, Rhiannon Garcia
-
Review of advanced practice nurse role in infection throughout the hematopoietic stem cell transplant journey Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-13 Maddie Gilsenan, Sam Van Der Linde, Geoff Hill, Belinda Lambros
BackgroundProlonged periods of immunosuppression during hematopoietic stem cell transplant (HSCT) can result in serious infectious complications and contribute to transplant‐related morbidity and mortality. Adherence to standardized pre and postinfection screening guidelines, prescribed medications, and early identification of infectious symptoms through comprehensive patient and family education are
-
Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-11 Bradley J. Gardiner, Steven P. Ivulich, Gregory I. Snell
-
Antibacterial prophylaxis for neutropenic and high‐risk hematology patients—Do the benefits outweigh the risk? Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-09 Gemma Reynolds, Julian Lindsay
CONFLICT OF INTEREST STATEMENT Julian Lindsay has served on advisory boards for Mayne Pharma, MSD, Amgen, and BMS. Gemma Reynolds has no relevant disclosures.
-
Unusual cause of biliary obstruction in a kidney transplant recipient with HIV Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-07 Ivana Juric, Danilo Radunovic, Irena Veliki Dalic, Pave Markos, Nikolina Basic‐Jukic
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Development of cytomegalovirus resistant to maribavir: real world, real problem? Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-02 Hanna L. Kleiboeker, Alyson Prom, Krista Paplaczyk
-
Multifocal cutaneous Mycobacterium ulcerans infection in a heart transplant recipient Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-02 Aadith Ashok, Victoria M. Warner, Bradley J. Gardiner
-
Advanced practice providers in infectious disease: Enhancing the infectious disease team of the future Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-02 Leah H. Yoke, Whitney Miller, Alison M. Beieler
As the infectious disease (ID) workforce encounters increasing demand for services with fewer physicians entering the field, advanced practice providers (APPs) in infectious disease offer a unique ability to enhance high‐quality patient care. However, little is known about their incorporation into ID, their utilization in immunocompromised settings, or their future use. This article reviews currently
-
Atypical pneumonia testing in transplant recipients Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-03-02 Fionna Feller, Paul Trubin, Maricar Malinis, Joshua S. Vogel, Jacob Merwede, David R. Peaper, Marwan M. Azar
BackgroundThe incidence of atypical pneumonia among immunocompromised patients is not well characterized. Establishing a diagnosis of atypical pneumonia is challenging as positive tests must be carefully interpreted. We aimed to assess the test positivity rate and incidence of atypical pneumonia in transplant recipients.MethodsA retrospective cohort study was conducted at the Yale New Haven Health
-
Underrecognized cause diarrhea in solid organ transplant: a report of astroviridae enteritis in liver transplant Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-26 Parker Wilson, Craig Rosenstengle, Cedric Spak
We present a case of a 72‐year‐old liver transplant recipient 7 years prior who presents to our hospital with general malaise, fatigue, low‐grade fevers, and watery diarrhea. He was found to have Astrovirus via PCR testing in a comprehensive stool panel. The patient's home mycophenolic acid was held upon admission, while cyclosporine was continued through his hospital stay. Generally, Astroviridae
-
Interesting case from Argentina: Kidney transplant recipient with skin lesions—A Latin American perspective Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-26 Marcelo Víctor Radisic, Guilherme Santoro Lopes, Alejandro Marcel Hasslocher‐Moreno, Emily M. Eichenberger, Victoria G. Hall, Natalia Rosana Pujato, Wanessa Trindade Clemente
-
Disseminated Scedosporium infection in the early post‐kidney transplant period Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-20 Madhumita Rao, Michael Casias, Maheen Z Abidi
-
Evolution of the impact of the COVID‐19 pandemic on heart transplant recipients: Decreasing risk, improving perspective Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-20 Juan Carlos López‐Azor García, Irene Marco, Javier González Martín, Francisco López‐Medrano, Andrea Eixerés‐Esteve, Pedro Caravaca Pérez, Javier de Juan Bagudá, Elena Ana López‐Jiménez, Fernando Arribas, Juan Francisco Delgado‐Jiménez, María Dolores García‐Cosío Carmena
Background and MethodsHeart transplant recipients (HTr) have a higher probability of suffer from severe coronavirus disease‐2019 (COVID‐19) in comparison to general population, but their risk has changed over the course of the pandemic in relation to various factors. We conducted a prospective study including all HTr at risk of COVID‐19 in a tertiary center between February 2020 and October 2022. The
-
Current management of SARS‐CoV‐2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-20 Alessandro Visentin, Elise Pickavance, Rafael San‐Juan, Paolo Antonio Grossi, Oriol Manuel, Jose M. Aguado
-
Designing and analyzing studies of coronavirus disease 2019 and post‐acute sequelae of severe acute respiratory syndrome coronavirus 2 among immunocompromised individuals Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-20 Victor DeGruttola, Saima Aslam
Observational studies of coronavirus disease 2019 (COVID‐19) among transplant candidates and recipients remain important as immunocompromised patients formed a very small proportion of patients included in COVID‐19 trials and large database analyses. We discuss methods that have been used in such analyses to evaluate the impact of vaccination on the risk of symptomatic COVID‐19 in such patients and
-
Hepatic granulomas in a pediatric liver transplant recipient Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-13 Giovanni Mulé, Jean de Ville de Goyet, Alessandra Mularoni
CONFLICT OF INTEREST STATEMENT The authors of this manuscript have no conflicts of interest to disclose.
-
Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-13 Me-Linh Luong, Yoshiko Nakamachi, Fernanda P. Silveira, Catherine O. Morrissey, Lara Danziger-Isakov, Erik A. M Verschuuren, Cameron R. Wolfe, Denis Hadjiliadis, Daniel C. Chambers, Jignesh K. Patel, Goran Dellgren, Miranda So, Geert M. Verleden, Emily A. Blumberg, Robin Vos, Michael Perch, Are M. Holm, Nicholas J. Mueller, Cecilia Chaparro, Shahid Husain
-
The nuts and bolts of transplant infectious disease training Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-13 Courtney E. Harris, Ghady Haidar, Ricardo M. La Hoz, Chelsea A. Gorsline, Rebecca N. Kumar
-
Cover Image Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-14 Stanley C. Jordan, Sandy Y. Joung, Minhao Wang, Teresa Anh Tran, Michelle Bravo, Hibah Masoom, Christine Chang, Marilyn Mendez, Nancy Sun, Jignesh Patel, Michelle Kittleson, Edwin Frias, John C. Prostko, Joseph E. Ebinger, Susan Cheng, Kimia Sobhani
-
Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-13 Erica J. Stohs, Anum Abbas, Alison Freifeld
Febrile neutropenia (FN) is common among hematologic malignancy patients, including recipients of hematopoietic cell transplantation (HCT) and cellular therapies such as chimeric antigen receptor (CAR)-T-cell therapy. Prompt empiric antibiotic use has been the mainstay for decades but a “one-size-fits-all” approach is no longer broadly accepted, as treatment-related infectious risk are more understood
-
Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-02-06 Matthew Ringer, Maricar Malinis, Dayna McManus, Matthew Davis, Sunish Shah, Paul Trubin, Jeffrey E. Topal, Marwan M. Azar
-
Advancing cytomegalovirus prevention in solid organ transplant recipients: The promise of cell-mediated immune assays Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-31 Vivek B. Beechar, Varun K. Phadke, Stephanie M. Pouch, Michael H. Woodworth
Cytomegalovirus (CMV) infections are a major source of morbidity and mortality in solid organ transplant recipients. Prophylactic, preemptive, and hybrid prevention strategies have traditionally been the mainstay of CMV prevention but there is growing interest in the use of CMV cell-mediated immune assays to inform novel approaches to risk stratification. Recent evidence suggests that CMV interferon-gamma
-
Kidney transplantation in patients on anti-tubercular therapy: A single centre observational study Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-25 Pallavi Prasad, Sahil Bagai, Vandana Prasad, Rahul Grover, Gagandeep Chhabra, Dinesh Khullar
-
The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-25 Emma G. Guare, Cory M. Hale, Jeffrey Sivik, Erik Lehman, Yoshika Inoue, Kevin Rakszawski, Natthapol Songdej, Myles Nickolich, Hong Zheng, Seema Naik, David Claxton, Witold Rybka, Raymond Hohl, Shin Mineishi, Kentaro Minagawa, Catharine I. Paules
-
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram-negative bacteria Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-24 Cecilia Bonazzetti, Matteo Rinaldi, Federica Cosentino, Milo Gatti, Maristela Pinheiro Freire, Alessandra Mularoni, Wanessa Trindade Clemente, Ligia Camera Pierrotti, Jose Maria Aguado, Paolo Grossi, Federico Pea, Pierluigi Viale, Maddalena Giannella
-
How low should we go? Potential and challenges of ultrasensitive CMV assays and solid organ transplantation Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-25 Camille Nelson Kotton
CONFLICT OF INTEREST STATEMENT The author has previously received honoraria for serving on scientific advisory boards for Roche Diagnostics and Abbott laboratories.
-
Cytomegalovirus related hospitalization costs among hematopoietic stem cell and solid organ transplant recipients treated with maribavir versus investigator-assigned therapy: A US-based study Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-14 Bob G. Schultz, Michael Bullano, Deepika Paratane, Krithika Rajagopalan
-
A practical guide to real-world implementation of pre-emptive therapy for Cytomegalovirus disease prevention in high-risk seronegative liver transplant recipients with seropositive donors Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-12 Madeleine R. Heldman, Bailey Dunn, Evan Clemens, Megan Henderson, Cynthia E. Fisher, Robert M. Rakita, Catherine E. Kling, Ajit P. Limaye
The Comparison of Antiviral Preventative Strategies In Liver Transplant (CAPSIL) study showed pre-emptive therapy (PET) to be superior to antiviral prophylaxis for Cytomegalovirus (CMV) disease prevention in high-risk CMV seronegative liver transplant recipients (LTRs) with seropositive donors (D+R−). Despite the statistical superiority of PET over prophylaxis in research settings, PET is perceived
-
The devil is in the details: Nuances of pre-emptive therapy for cytomegalovirus disease prevention in high-risk seropositive donors liver transplant recipients Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-08 Madeleine R. Heldman, Ajit P. Limaye
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: Incidence, clinical management, and outcome Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-08 Elisa Balletto, Marta Ponzano, Anna Maria Raiola, Massimiliano Gambella, Carmen Di Grazia, Alida Dominietto, Livia Giannoni, Anna Ghiso, Laura Ambra Nicolini, Chiara Sepulcri, Nadir Ullah, Bianca Bruzzone, Alessio Signori, Emanuele Angelucci, Matteo Bassetti, Malgorzata Mikulska
-
COVID-19 in organ donors: An organ procurement organization perspective Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-08 Alyssa K. Mezochow, Judith Anesi, Sharon West, Richard Hasz, John Edwards, Emily A. Blumberg
-
Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID-19 infection at an ambulatory cancer center Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-08 Eduardo Sanchez, Elizabeth M Krantz, Leah Yoke, Molly Gallaher, Pooja Bhattacharyya, Lisa So, Zahra Kassamali Escobar, Frank Tverdek, Emily A Rosen, ZZ Quinn, Michelle Swetky, Salma Walji, Marie H. Wilson, Brittany McCreery, Denise McCulloch, Amelia Weixler, Pavitra Roychoudhury, Steven A Pergam, Catherine Liu
-
Incidence of valganciclovir-related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-05 Sara Belga, Cristina Hernandez, Dima Kabbani, Carlos Cervera
-
Epidemiology of bloodstream infections and the impact of antimicrobial resistance in pediatric hematopoietic cell transplant Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-05 Fabianne Carlesse, Chiara Russo, Adriana Seber, Elio Castagnola
Bloodstream infections (BSI) pose a substantial threat to the well-being and survival of patients undergoing hematopoietic stem cell transplantation (HSCT). Risk factors for these infections vary across the different post-HSCT phases. In the pre-engraftment period, patients are particularly susceptible to infection due to prolonged neutropenia, mucosal damage, and extensive use of central venous line
-
Five-year single-center analysis of cytomegalovirus viremia in kidney transplant recipients and possible implication for novel prophylactic therapy approaches Transpl. Infect. Dis. (IF 2.6) Pub Date : 2024-01-05 Moritz Trappe, Patrick Affeldt, Franziska Grundmann, Martin Kann, Felix C. Koehler, Roman-Ulrich Müller, Dirk Stippel, Rolf Kaiser, Elena Knops, Eva Heger, Gertrud Steger, Florian Klein, Christine Kurschat, Veronica Di Cristanziano
-
Intrauterine devices are a safe form of contraception in users with solid organ transplantation: A single-center experience Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-31 Stephanie I. Amaya, Sharon F. Wolff, Meghan Ross, Valerie A. French
-
Donor blood cultures and outcomes after lung transplantation: a single-center report Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-31 Mahmoud Hashim, Rana Ahmed Saleh, Rayid Abdulqawi, Chams Alkhalaf Albachir, Haifa Aldakhil, Khaled Manae AlKattan, Reem Saad Almaghrabi, Alaa Hamad, Waleed Saleh, Eid Abdullah Al-Mutairy
-
Post-transplant lymphoproliferative disorder in pediatric liver transplant recipients: Experience from a South African transplant center Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-28 Priya Walabh, David P Moore, Christina Hajinicolaou
-
Impact of an ultrasensitive Cytomegalovirus quantitative nucleic acid test on Cytomegalovirus detection and therapy in renal transplant recipients Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-30 Vivek B. Beechar, Stephanie M. Pouch, Varun K. Phadke, Geeta Karadkhele, Christian P. Larsen, Michael H. Woodworth
-
Evaluation of ear, nose, and throat-screening in liver transplantation candidates: A retrospective cohort study Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-27 Eline Beukman, Adriaan J. van der Meer, R. Bart Takkenberg, Caroline M. den Hoed, Andries Paul Nagtegaal
-
Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-19 Laura A. Binari, Peter Thorne, Scott A. Rega, Irene D. Feurer, Saed Shawar, Ruchi Naik, Kelly A. Birdwell, J. Harold Helderman, Anthony Langone, Bonnie Ann Sarrell, Heidi Schaefer, Bernard John DuBray, Kareem Eid, Laura Hickman, David Shaffer, Beatrice P. Concepcion, Rachel C. Forbes
-
A low thrombospondin-1 serum concentration is related to increased bacteremia risk in lymphoma patients treated with BeEAM/BEAM conditioning regimen and autologous stem cell transplantation Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-19 Kacper Kościelny, Damian Mikulski, Mateusz Nowicki, Krystyna Wyka, Małgorzata Misiewicz, Ewelina Perdas, Agnieszka Wierzbowska, Wojciech Fendler
-
Clinical impact of preservation fluid contamination on kidney transplant patients Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-09 Natalia Picola Brau, Maria Fiol Riera, Begoña Etcheverry Giadrosich, Lluis Riera Canals, Edoardo Melilli, Núria Sabé Fernández, Manel Castells Esteve, Francesc Vigués Julià
-
Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-07 Jade M. Kozuch, Carrie Burt, Kamyar Afshar, Saima Aslam, Gordon Yung, Mark Mariski, Eugene Golts, Ashley Feist
-
Stopping antibacterial prophylaxis in pediatric allogeneic hematopoietic cell transplantation: An internal audit Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-06 Nina Wintjes, Katja Krämer, Hedwig Kolve, Daniela Mohring, Frieder Schaumburg, Claudia Rossig, Birgit Burkhardt, Andreas H. Groll
-
Heart of the matter—infection and xenotransplantation Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-06 Kapil K. Saharia, , Victoria G. Hall, Supavit Chesdachai, Paige Porrett, Jay A. Fishman, Stephanie M. Pouch
-
Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-02 Yonatan Diamond, Maddie Gilsenan, Stacie Shiqi Wang, Diane Hanna, Rachel Conyers, Theresa Cole, David Hughes, Jacqueline Fleming, Deborah Meyran, Claudia Toro, Vajiranee Malalasekera, Seong Lin Khaw, Gabrielle M. Haeusler
CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy is transforming care for pediatric patients with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). There are limited pediatric-specific data concerning the infection risks associated with CD19 CAR-T therapy and the adequacy of current antimicrobial prophylaxis guidelines for these patients.
-
Emphysematous gastritis due to Sarcina ventriculi infection in an immunocompromised adult Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-01 Sean E. Kisch, Jasmine Walker, Annette E. Hebert, Annika L. Windon, Kevin Christopher Dee, Sara M. Haddad, Anthony Langone, Marcus C. B. Tan
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
A case of skin and soft tissue infection in a lung transplant recipient Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-01 Flavia Moran Viacava, Maria Veronica Bandres, Aaron Mishkin
CONFLICT OF INTEREST STATEMENT Aaron Mishkin receives grant support paid to Temple University from Pfizer, Inc. Other authors have no conflict of interest.
-
Hematopoietic stem cell transplantation and the noncytomegalovirus herpesviruses Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-12-01 Vanessa R. Wormser, Nelson Iván Agudelo Higuita, Ramya Ramaswami, Dante P. Melendez
Although hematopoietic stem cell transplantation (HSCT) and other cellular therapies have significantly improved outcomes in the management of multiple hematological and nonhematological malignancies, the resulting impairment in humoral and cellular response increases the risk for opportunistic infection as an undesirable side effect. With their ability to establish latent infection and reactivate
-
When a fungal infection is worse than a leukemia diagnosis. Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-11-27 Julie-Ann Attard,Madeleine Attard
-
Excess mortality among kidney transplant recipients: Impact of COVID-19-related deaths during the pandemic Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-11-27 Marina Pontello Cristelli, Carlos Magno Castelo Branco Fortaleza, João Filipe Costa Alves Pereira, Julia Bernardi Taddeo, Laila Almeida Viana, Lucio Roberto Requião-Moura, Charles Yea Zen Chow, Monica Rika Nakamura, Helio Tedesco-Silva, José Medina-Pestana
-
Risk factors for positive follow-up blood cultures in Gram-negative bacteremia among immunocompromised patients with neutropenia Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-11-27 Nischal Ranganath, Zachary A. Yetmar, Omar Abu Saleh, Aaron J. Tande, Aditya S. Shah
-
Detrimental impact of immunosuppressive burden on clinical course in patients with Cytomegalovirus infection after liver transplantation Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-11-27 Ramin Raul Ossami Saidy, Stefanie Kollar, Zoltan Czigany, Luca Dittrich, Nathanael Raschzok, Brigitta Globke, Wenzel Schöning, Robert Öllinger, Georg Lurje, Johann Pratschke, Dennis Eurich, Deniz Uluk
-
Severe COVID-19 in solid organ transplant recipients in the post-vaccination era: Persistence in the burden of disease and in disparities of care Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-11-27 Abhay Dhand, Kenji Okumura, Seigo Nishida
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Impact of preoperative bloodstream infection on outcomes of pediatric liver transplant recipients treated for acute liver failure Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-11-27 Chiaki Baba, Takanori Funaki, Makoto Uranaka, Mai Hashiya, Jun Ninagawa, Seisuke Sakamoto, Mureo Kasahara, Yasuko Nagasaka, Yasuyuki Suzuki, Shugo Kasuya
-
Meet in the middle: Could cell mediated-immunity assays be the answer for ideal Cytomegalovirus prophylaxis after lung transplantation? Observational study from a single center with intermittent antiviral prophylaxis Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-11-21 Sílvia Vidal Campos, Lisete Ribeiro Teixeira, Maristela Pinheiro Freire, Ana Carolina Mamana, Clarisse Martins Machado
-
Shifting landscape of infectious diseases in hematologic malignancies: A hematopoietic cell transplantation and cellular therapy special edition. Transpl. Infect. Dis. (IF 2.6) Pub Date : 2023-11-21 Gabrielle M Haeusler,Jan Styczynski,Andrea J Zimmer